Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
1K
-
Shares change
-
-33.5K
-
Total reported value, excl. options
-
$2K
-
Value change
-
-$100K
-
Number of sells
-
-3
-
Price
-
$2.00
Significant Holders of Lexaria Bioscience Corp. - COM NEW (LEXX) as of Q3 2022
5 filings reported holding LEXX - Lexaria Bioscience Corp. - COM NEW as of Q3 2022.
Lexaria Bioscience Corp. - COM NEW (LEXX) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1K shares
.
Largest 10 shareholders include CITADEL ADVISORS LLC (24.9K shares), WELLS FARGO & COMPANY/MN (1K shares), CITIGROUP INC (0 shares), Merit Financial Group, LLC (0 shares), Virtu Financial LLC (0 shares), Invenomic Capital Management LP (473K shares), GEODE CAPITAL MANAGEMENT, LLC (49K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (40.1K shares), VANGUARD GROUP INC (33.2K shares), and DIMENSIONAL FUND ADVISORS LP (15.3K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.